# Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment

> **NCT00530686** · PHASE1 · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 1 (actual)

## Conditions studied

- Islet Cell Transplantation
- Type 1 Diabetes

## Interventions

- **DRUG:** Islet cell transplantation

## Key facts

- **NCT ID:** NCT00530686
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530686, "Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00530686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*